Absence of Increased Susceptibility to Acetaminophen-Induced Liver Injury in a Diet-Induced NAFLD Mouse Model
Toxicologic Pathology · 2023
DOI: 10.1177/01926233231171101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicologic Pathology, 2023. Verfasst von Takeshi Izawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Comparative and Molecular Pathogenesis Branch, Division of Translational Toxicology, National Institute of Environmental Health Services, Research Tr…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Chemical and Drug Induced Liver Injury, Chronic, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, DNTP/NIEHS intramural program, JSPS (Japan Society for the Promotion of Science) Fund for the Promotion of Joint International Research.
Abstract (Originalsprache)
Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease and its influence on drug-induced liver injury (DILI) is not fully understood. We investigated whether NAFLD can influence acetaminophen (APAP [N-acetyl-p-aminophenol])-induced hepatotoxicity in a diet-induced obese (DIO) mouse model of NAFLD. The male C57BL/6NTac DIO mice, fed a high-fat diet for more than 12 weeks, developed obesity, hyperinsulinemia, impaired glucose tolerance, and hepatomegaly with hepatic steatosis, similar to human NAFLD. In the acute toxicity study after a single dose of APAP (150 mg/kg), compared with control lean mice, the DIO mice had decreased serum transaminase levels and less severe hepatocellular injury. The DIO mice also had altered expression of genes related to APAP metabolism. Chronic APAP exposure for 26 weeks did not predispose the DIO mice with NAFLD to more severe hepatotoxicity compared with the lean mice. These results suggested that the C57BL/6NTac DIO mouse model appears to be more tolerant to APAP-induced hepatotoxicity than lean mice, potentially related to altered xenobiotic metabolizing capacity in the fatty liver. Further mechanistic studies with APAP and other drugs in NAFLD animal models are necessary to investigate the mechanism of altered susceptibility to intrinsic DILI in some human NAFLD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Comparative and Molecular Pathogenesis Branch, Division of Translational Toxicology, National Institute of Environmental Health Services, Research Triangle Park, North Carolina, USA.
- Osaka Metropolitan University, Osaka, Japan.
- Experimental Pathology Laboratories, Inc., Research Triangle Park, North Carolina, USA.
ORCID-Profile: Takeshi Izawa, Arun R Pandiri
Förderung
- Intramural NIH HHS
- DNTP/NIEHS intramural program
- JSPS (Japan Society for the Promotion of Science) Fund for the Promotion of Joint International Research
Zitieren
APA
Izawa, T., Travlos, G. S., Cortes, R. A., Clayton, N. P., Sills, R. C., & Pandiri, A. R. (2023). Absence of Increased Susceptibility to Acetaminophen-Induced Liver Injury in a Diet-Induced NAFLD Mouse Model. Toxicologic Pathology. https://doi.org/10.1177/01926233231171101
Vancouver
Izawa T, Travlos GS, Cortes RA, Clayton NP, Sills RC, Pandiri AR. Absence of Increased Susceptibility to Acetaminophen-Induced Liver Injury in a Diet-Induced NAFLD Mouse Model. Toxicologic Pathology. 2023. doi:10.1177/01926233231171101
BibTeX
@article{Izawa2023,
author = {Izawa, Takeshi and Travlos, Gregory S and Cortes, Ricardo A and Clayton, Natasha P and Sills, Robert C and Pandiri, Arun R},
title = {Absence of Increased Susceptibility to Acetaminophen-Induced Liver Injury in a Diet-Induced NAFLD Mouse Model},
journal = {Toxicologic Pathology},
year = {2023},
doi = {10.1177/01926233231171101}
}
EUVIMED